These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16955468)

  • 21. Nonrandom karyotype abnormalities in 36 multiple myeloma patients.
    Ankathil R; Madhavan J; Gangadharan VP; Pillai GR; Nair MK
    Cancer Genet Cytogenet; 1995 Aug; 83(1):71-4. PubMed ID: 7656209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissecting karyotypic patterns in colorectal tumors: two distinct but overlapping pathways in the adenoma-carcinoma transition.
    Höglund M; Gisselsson D; Hansen GB; Säll T; Mitelman F; Nilbert M
    Cancer Res; 2002 Oct; 62(20):5939-46. PubMed ID: 12384560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polysomy 8 in three cases of homologous malignant mixed Müllerian tumors of the uterus.
    Gunawan B; Baumhoer D; Schulten HJ; Emons G; Füzesi L
    Anticancer Res; 2003; 23(2B):1379-83. PubMed ID: 12820397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interphase fluorescence in situ hybridization in multiple myeloma and monoclonal gammopathy of undetermined significance without and with positive plasma cell identification: analysis of 192 cases from the Region of Southern Denmark.
    Christensen JH; Abildgaard N; Plesner T; Nibe A; Nielsen O; Sørensen AG; Kerndrup GB;
    Cancer Genet Cytogenet; 2007 Apr; 174(2):89-99. PubMed ID: 17452249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer-causing karyotypes: chromosomal equilibria between destabilizing aneuploidy and stabilizing selection for oncogenic function.
    Li L; McCormack AA; Nicholson JM; Fabarius A; Hehlmann R; Sachs RK; Duesberg PH
    Cancer Genet Cytogenet; 2009 Jan; 188(1):1-25. PubMed ID: 19061776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fluorescence in situ hybridization identifies complex chromosomal aberrations in multiple myeloma].
    Liu SY; Huang JW; Zhang J; Du HP; Jiang H; Li JY; Xue YQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):685-8. PubMed ID: 18067084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
    Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
    Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for telomeric fusions as a mechanism for recurring structural aberrations of chromosome 11 in giant cell tumor of bone.
    Sawyer JR; Goosen LS; Binz RL; Swanson CM; Nicholas RW
    Cancer Genet Cytogenet; 2005 May; 159(1):32-6. PubMed ID: 15860354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of whole chromosome gains in tumors--many answers to a simple question.
    Gisselsson D
    Cytogenet Genome Res; 2011; 133(2-4):190-201. PubMed ID: 21124017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas.
    Höglund M; Sehn L; Connors JM; Gascoyne RD; Siebert R; Säll T; Mitelman F; Horsman DE
    Genes Chromosomes Cancer; 2004 Mar; 39(3):195-204. PubMed ID: 14732921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormalities of chromosome 1p/q are highly associated with chromosome 13/13q deletions and are an adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma.
    Wu KL; Beverloo B; Lokhorst HM; Segeren CM; van der Holt B; Steijaert MM; Westveer PH; Poddighe PJ; Verhoef GE; Sonneveld P; ;
    Br J Haematol; 2007 Feb; 136(4):615-23. PubMed ID: 17223915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlating breakage-fusion-bridge events with the overall chromosomal instability and in vitro karyotype evolution in prostate cancer.
    Vukovic B; Beheshti B; Park P; Lim G; Bayani J; Zielenska M; Squire JA
    Cytogenet Genome Res; 2007; 116(1-2):1-11. PubMed ID: 17268171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic Aberrations in Multiple Myeloma.
    Manier S; Salem K; Glavey SV; Roccaro AM; Ghobrial IM
    Cancer Treat Res; 2016; 169():23-34. PubMed ID: 27696256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncogenetic tree models based on cytogenetic data: new insights into the development of epithelial tumors of the thymus.
    Rieker RJ; Penzel R; Aulmann S; Blaeker H; Morresi-Hauf A; Hecker E; Otto HF; Mechtersheimer G; von Heydebreck A
    Cancer Genet Cytogenet; 2005 Apr; 158(1):75-80. PubMed ID: 15771909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ploidy status rarely changes in myeloma patients at disease progression.
    Chng WJ; Winkler JM; Greipp PR; Jalal SM; Bergsagel PL; Chesi M; Trendle MC; Ahmann GJ; Henderson K; Blood E; Oken MM; Hulbert A; Van Wier SA; Santana-Dávila R; Kyle RA; Gertz MA; Lacy MQ; Dispenzieri A; Fonseca R
    Leuk Res; 2006 Mar; 30(3):266-71. PubMed ID: 16111750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene expression profiling and gene copy-number changes in malignant mesothelioma cell lines.
    Zanazzi C; Hersmus R; Veltman IM; Gillis AJ; van Drunen E; Beverloo HB; Hegmans JP; Verweij M; Lambrecht BN; Oosterhuis JW; Looijenga LH
    Genes Chromosomes Cancer; 2007 Oct; 46(10):895-908. PubMed ID: 17620293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On the karyotypic origin and evolution of cancer cells.
    Nicholson JM; Duesberg P
    Cancer Genet Cytogenet; 2009 Oct; 194(2):96-110. PubMed ID: 19781442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific patterns of chromosomal gains and losses associate with t(3;14), t(8;14), and t(14;18) in diffuse large B-cell lymphoma.
    Sheth A; de Melo VA; Szydlo R; Macdonald DH; Reid AG; Wagner SD
    Cancer Genet Cytogenet; 2009 Oct; 194(1):48-52. PubMed ID: 19737654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple myeloma primary cells show a highly rearranged unbalanced genome with amplifications and homozygous deletions irrespective of the presence of immunoglobulin-related chromosome translocations.
    Largo C; Saéz B; Alvarez S; Suela J; Ferreira B; Blesa D; Prosper F; Calasanz MJ; Cigudosa JC
    Haematologica; 2007 Jun; 92(6):795-802. PubMed ID: 17550852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular cytogenetic analysis of follicular lymphoma (FL) provides detailed characterization of chromosomal instability associated with the t(14;18)(q32;q21) positive and negative subsets and histologic progression.
    Nanjangud G; Rao PH; Teruya-Feldstein J; Donnelly G; Qin J; Mehra S; Jhanwar SC; Zelenetz AD; Chaganti RS
    Cytogenet Genome Res; 2007; 118(2-4):337-44. PubMed ID: 18000388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.